4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-034146
Chief Executive Officer sold 1,207 shares at $2.81 ($3,392)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-10-25 | Sale | −1,207 | $2.81 | $3,392 | 251,093 | D |
| Open-market sales · 1,207 sh · avg $2.81 · $3,392 | |||||||
Loading xslF345X03/doc4.xml…